Biotech Investment Essentials: How to Invest in Biotechnology and Life Sciences Sectors

Author: Mark Tang
Publisher:
Publish Date: 2005-01-01
Features:
Introduction The author has a solid educational background in biotechnology and corporate finance, along with extensive practical experience in investment. Based on an introduction to the fundamental knowledge of biotechnology and basic investment concepts, this book focuses on the specific field of biotechnology, combining the author's real-world experience in the U.S. and concrete examples to concisely discuss the categories, relevant theories, basic principles, risk avoidance, investment selection, and investment techniques in biotechnology industry investments. The book's strength lies not in the systematicity or depth of investment theory, but in its strong focus on biotechnology and life sciences, serving as a bridge between biotechnology and industrial investment. It provides industry investment knowledge and a comprehensive professional knowledge system for biologists, biotechnologists, and students in related fields, helping to establish the concept of knowledge industrialization and determine research and practical directions. At the same time, it offers reference material for industry or investment professionals to understand the development and value of the biotechnology industry.
Table of Contents Preface The Biotech Stock That Increases Your Wealth: A Necessary Part of Asset Allocation
1. The Benefits of the Biotech Revolution to Society
2. The Exceptional Performance of the Biotech Sector
3. Strong Foundations and Product Lines
4. Robust Revenue and Profit Growth
5. The Difference Between Biotech Companies and Internet Companies
6. Stocks as a Must-Have for Wealth Growth
7. Stocks Beyond Inflation
8. Why Choose Biotechnology?
9. Favorable Demographics: The Rapid Population Growth of Baby Boomers
10. Favorable Trends
11. Favorable Technological Trends
12. Large Pharma and Biotech: Complementary Forces
13. Supply and Demand Imbalance?
Chapter 1 Investment Basics
1. Stock Examples
2. The 2072 Rule
3. The Power of Diversification
4. Opportunity Cost
5. The Relationship Between Risk and Return
6. Dollar-Cost Averaging
7. Purchasing Power and Inflation—Are Certificates of Deposit (CDs) Really Safe?
8. Holding Periods and Risk
9. Understanding Risk
10. Diversification—Reducing Your Investment Risk
11. Historical Reasons Not to Invest
12. Historical Investment Returns and Expected Returns
13. Technical Analysis
14. Paths to Achieving Investment Goals
- Path 1: Stocks
- Path 2: Bonds
- Path 3: Cash
- Path 4: Mutual Funds
- Path 5: Unit Investment Trusts
- Path 6: Managed Accounts
- Path 7: Alternative Investments
15. Asset Allocation
16. Managing Your Investments and Wealth
Chapter 2 Biotechnology and Genomics
Chapter 3 Understanding Biotech Innovation and FDA Approval Processes
Part 1: Biotech Innovation and Patents
Part 2: FDA Drug Approval Process
FDA Approval Process Stages
Drug Evaluation Terms
Chapter 4 Investing in Biotechnology
1. Investment Evaluation
2. Growth Investing
3. Industry Cycles
4. Characteristics of Biotech Investing
5. Value Investing
6. Principles of Biotech Investing
7. The Key to Winning for Biotech Companies
Chapter 5 How to Evaluate and Invest in a Biotech Company
Step 1: Economic and Business Cycles
Step 2: Industry Sector Analysis
Step 3: Analyzing a Biotech Company
Part 1: Should I Buy This Biotech Stock?
- Method 1: Fundamental Analysis
- Method 2: Discounted Cash Flow (DCF) Valuation
- Method 3: "Sum-of-the-Parts" Valuation
- Method 4: Dividend Discount Model (DDM)
- Method 5: Subscription-Based Valuation
- Method 6: Economic Value Added (EVA)
- Method 7: Earnings-Based Valuation—An Example of Market Valuation
- Qualitative Components of Valuation
8. Risks of Biotech Companies
9. Summary: Which Valuation Model Fits Biotech Companies Best?
Part 2: Investing in Undervalued Healthcare Biotech Companies—Healthcare Proactive Value Investing
Chapter 6 Investing in Biotech Mutual Funds
1. Don't Put All Your Eggs in One Basket
2. Purchasing Power
3. Professional Management
4. Asset Allocation
5. Liquidity
6. Investment Rules and Discipline
7. Dollar-Cost Averaging
8. Case Study: Index Funds
9. Why Invest in Stocks or Stock Mutual Funds?
10. The Cost of Waiting
11. Benefits of Investing in Biotech Mutual Funds
Chapter 7 Healthcare Biotech Index Investing: Exchange-Traded Funds (ETFs) and BOXES
1. Case Study: Index Funds
2. Exchange-Traded Funds (ETFs)
- Advantages of ETFs
- ETFs Tied to Indexes
3. Index Investing
4. Strategies for Applying Biotech and Pharmaceutical BOXES
Chapter 8 Risk Management for Biotech Investors with Concentrated Positions
1. Option 1: Hold Your Stocks, But Be Aware of the Risks
2. Option 2: Sell All Your Stocks and Reinvest
3. Option 3: Avoid Liquidation and Diversification Strategies
4. Summary
Glossary
Chapter 9 Managing Biotech Stock Employee Stock Options (ESOs): Employee Benefits
Glossary of Terms
Four Common Phased Vesting Methods
Non-Qualified Biotech Stock ESOs
Incentive Biotech Employee Stock Options
Your Biotech Employee Stock Option Plan
Optional Biotech Stock Acquisition Plans
83(b) Election
Chapter 10 Introduction to Healthcare Biotech Leveraged Fund Investing
1. Leveraged Fund Investment Style
2. Three Ways to Participate in Healthcare Biotech Leveraged Funds
3. Due Diligence Before Investing in Healthcare Biotech Leveraged Funds
4. Conclusion
5. Overview of Leveraged Fund Strategies
Chapter 11 Introduction to Healthcare Biotech Private Equity Investing
1. Healthcare Biotech Venture Capital
- The Four Steps of Healthcare Biotech Venture Capital
2. Healthcare Buyout Funds
3. Special Considerations in Healthcare
- Key Considerations
- Five Basic Ways to Participate in Healthcare Private Equity Investing
- Performance Metrics for Healthcare Biotech Private Equity Funds
4. Conclusion
Chapter 12 Retirement Planning for Biotech Executives and Investors
1. Career Changes: Impact on Your Retirement Savings
2. Direct and Indirect Rollovers: Rolling Over into an IRA
3. Tax-Deferred Rollovers
4. Retirement Strategies
Chapter 13 Charitable Disposition of Appreciated Biotech Stocks
1. Private Foundations
2. Charitable Remainder Trusts
3. Conclusion
4. Choosing a Charitable Giving Plan Through a National Charitable Trust
Chapter 14 Managing Your Biotech Wealth: Estate Planning for Biotech Investors, Executives, and Entrepreneurs
Trust Strategies to Minimize Estate Taxes
Conclusion
Afterword
Appendix 1: What Is Technical Analysis?
1. Dow Theory
2. Four Groups of Technical Indicators
3. Analyzing the Big Picture Before Focusing on Individual Stocks
4. Chart Patterns That Indicate Reversals in Stock Price Trends
5. Chart Patterns That Indicate Plateaus in Stock Price Trends
Appendix 2: Biotech and Life Science Glossary
Appendix 3: Financial Glossary
Appendix 4: References and Recommended Reading
- Books
- Websites
- Newsletters
- Newspapers and Journals